Results 271 to 280 of about 35,454 (303)
Some of the next articles are maybe not open access.

Allergic contact dermatitis to pimecrolimus

Contact Dermatitis, 2006
Pimecrolimus suppresses the proinflammatory cytokine production of cutaneous T and mast cells (1). It is used to treat atopic dermatitis and is the active ingredient in the topical formulation pimecrolimus 1.0% cream (ElidelĀ®, Novartis Pharma AG, Basel, Switzerland).
Peter, Saitta, Ronald, Brancaccio
openaire   +2 more sources

Immunotherapy of Allergic Contact Dermatitis

Immunotherapy, 2011
The term 'immunotherapy' refers to treating diseases by inducing, enhancing or suppressing immune responses. As allergy is an excessive, detrimental immune reaction to otherwise harmless environmental substances, immunotherapy of allergic disease is aimed at the induction of tolerance toward sensitizing antigens.
openaire   +2 more sources

Allergic Contact Dermatitis

Medical Journal of Australia, 1978
openaire   +2 more sources

Allergic Contact Dermatitis

Veterinary Clinics of North America, 1974
openaire   +2 more sources

Allergic Contact Dermatitis

International Journal of Dermatology, 1985
openaire   +2 more sources

Allergic contact dermatitis in caterers

Contact Dermatitis, 1993
M C, Acciai   +4 more
openaire   +2 more sources

Allergic contact dermatitis to phenylephrine

Contact Dermatitis, 1986
G, Ducombs   +3 more
openaire   +2 more sources

Allergic Contact Dermatitis and Orthodontics

Pediatric Allergy, Immunology, and Pulmonology, 2023
openaire   +2 more sources

Home - About - Disclaimer - Privacy